Men and women who are 18+, with schizophrenia or schizoaffective
disorder, are invited to be involved in an adjunctive treatment study
that is underway in Melbourne. Hormones are known to play a role in the
expression of schizophrenia and related disorders. The
is investigating whether a treatment that
targets hormones, when taken in combination with regular antipsychotic
medication, can better improve psychotic symptoms, mood and cognitive
functioning. Participants will be reimbursed for their time and travel
can be negotiated. See more:
This
MAPrc study will examine important safety aspects (such as agitation, aggression and depression) of the drugs varenicline and bupropion compared to placebo (“dummy pills” that do not contain any medicine) and nicotine-replacement therapy (NRT or “the patch”) in smokers with or without a history of being diagnosed with a psychiatric disorder. See more:
Link
 |
| Image: Debbra Sweet |
We have created an index page which lists research studies being undertaken by various Departments within Central Clinical School which are seeking participants. You can login with your Monash authcate and add your own study. We get an email to prompt the publication of the entry and disseminate it more widely.
Studies are investigating a wide range of diseases, including allergies, Irritable Bowel Syndrome and gluten intolerance, schizophrenia and depression. The studies may seek both well and unwell participants. See
index page which links to detail for each study currently seeking participants:
Research study index link
08/04/2014 Research being undertaken by the Monash Alfred Psychiatry research centre (MAPrc) is said to be investigating whether adding raloxifene, or 'brain
estrogen', to current anti-psychotic treatment can further improve the
symptoms of schizophrenia, including psychotic, mood and cognitive
symptoms.
09/04/2014 Professor Paul O'Brien, Department of Surgery, has released
research indicating lap band surgery can help treat type 2 diabetes.
15/04/2014 Professor Fabienne Mackay, Head of the Department of Immunology, commented on the
development of new therapeutic strategies which could see better
survival rates of people suffering from chronic lymphocytic leukaemia.
The Victorian government is sponsoring the Molecules to Medicines intern program to provide practical on-the-job training and mentoring for researchers in technology transfer, translation and the commercial development of biomedical discoveries. Further information can be found at www.molecules2medicine.org. All students/post docs interested in this program must submit a CV and a brief statement why they wish to pursue this course to Dr Steven Petratos (Central Clinical School) steven.petratos@monash.edu by 31 May 2014. Read more » 
Men and women who are 18+, with schizophrenia or schizoaffective
disorder, are invited to be involved in an adjunctive treatment study
that is underway in Melbourne. Hormones are known to play a role in the
expression of schizophrenia and related disorders. The Monash Alfred Psychiatry research centre is investigating whether a treatment that
targets hormones, when taken in combination with regular antipsychotic
medication, can better improve psychotic symptoms, mood and cognitive
functioning. Participants will be reimbursed for their time and travel
can be negotiated. See more: Link.jpg)
